Quick Answer
HAEMONETICS CORP reported Net Income Loss of $167.68 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +42.6% in Net Income Loss from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: -$10.35 million | Q3 2016: $19.83 million | Q4 2016: $15.39 million | Q1 2017: -$51.14 million | Q2 2017: $20.14 million | Q3 2017: $20.10 million | Q4 2017: -$6.55 million | Q1 2018: $11.88 million | Q2 2018: -$2.82 million | Q3 2018: $18.73 million | Q4 2018: -$8.48 million | Q1 2019: $20.84 million | Q2 2019: -$8.48 million | Q3 2019: $37.49 million | Q4 2019: $29.90 million | Q1 2020: $17.62 million | Q2 2020: $10.53 million | Q3 2020: $48.10 million | Q4 2020: $31.88 million | Q1 2021: -$11.04 million | Q2 2021: -$4.45 million | Q3 2021: $14.86 million | Q4 2021: $23.23 million | Q2 2022: $19.88 million | Q3 2022: $33.20 million | Q4 2022: $32.94 million | Q2 2023: $41.04 million | Q3 2023: $24.91 million | Q4 2023: $31.24 million | Q2 2024: $38.37 million | Q3 2024: $33.83 million | Q4 2024: $37.49 million | Q2 2025: $34.03 million | Q3 2025: $38.68 million | Q4 2025: $44.74 million.
- Over the full 17 years of available data (2009 to 2025), HAEMONETICS CORP's Net Income Loss has grown by 182.7%.
- Historical annual values: Fiscal year 2025: $167.68 million | Fiscal year 2024: $117.56 million | Fiscal year 2023: $115.40 million | Fiscal year 2022: $43.38 million | Fiscal year 2021: $79.47 million | Fiscal year 2020: $76.53 million | Fiscal year 2019: $55.02 million | Fiscal year 2018: $45.57 million | Fiscal year 2017: -$26.27 million | Fiscal year 2016: -$55.58 million | Fiscal year 2015: $16.90 million | Fiscal year 2014: $35.15 million | Fiscal year 2013: $38.80 million | Fiscal year 2012: $66.89 million | Fiscal year 2011: $79.98 million | Fiscal year 2010: $58.37 million | Fiscal year 2009: $59.30 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: